See also this year's filing and all EDGAR filings for this company.
PDF Report 0001001316_2016_TG_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001001316, TG Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 86,873,331 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 799,391 |
| 2 | PropertyPlantAndEquipmentNet | 47,122 |
| 3 | remainder_Assets | 25,753,357 |
| 4 | LiabilitiesCurrent | 10,528,470 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 1,371,429 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,625,174 |
| 9 | ResearchAndDevelopmentExpense | 47,707,223 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 383,751 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 113,473,201 |
| 1 | Liabilities | 11,899,899 |
| 2 | Expenses | 63,332,397 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 101,573,302 |
| 5 | NetIncome | -62,948,646 |
| 6 | ComprehensiveNetIncome | -62,948,646 |
| 7 | BaseVar | 94,544,624 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.53 |
| 9 | EconomicCapitalRatio | 3.37 |
Edgar->Model Mapping
Feature Distribution
Change over Time
